First case of type E wound botulism diagnosed using real-time PCR

Journal of Clinical Microbiology

Volumn 45, Issue 11, 2007, Pages 3589-3594

  Artin, Ingrid ^a,b   Björkman, Per ^c   Cronqvist, Jonas ^c   Radström, Peter ^b   Holst, Elisabet ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND INSTITUTE OF TECHNOLOGY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTOXIN;

ADULT; ARTICLE; BACTERIAL GENE; BOTULISM; CASE REPORT; CLOSTRIDIUM BOTULINUM; DIAGNOSTIC PROCEDURE; FEMALE; GENE AMPLIFICATION; HUMAN; INTRAVENOUS DRUG ABUSE; LABORATORY DIAGNOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SWEDEN; WOUND INFECTION;

CLOSTRIDIUM BOTULINUM;

EID: 36349011454     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01192-07     Document Type: Article

References (36)

1. Akbulut, D., J. Dennis, M. Gent, K. Grant, V. Hope, C. Ohai, J. McLauchlin, V. Mithani, O. Mpamugo, F. Ncube, and L. De Souza-Thomas. 2005. Wound botulism in injectors of drugs: upsurge in cases in England during 2004. Euro Surveill. 10:172-174.
2. Akbulut, D., K. A. Grant, and J. McLauchlin. 2004. Development and application of real-time PCR assays to detect fragments of the Clostridium botulinum types A, B, and E neurotoxin genes for investigation of human foodborne and infant botulism. Foodborne Pathog. Dis. 1:247-257.
3. Alpers, K., U. van Treeck, and C. Frank. 2005. Outbreak of wound botulism in injecting drug users in Germany, October-December 2005. Euro Surveill. 10:E051215.4.
4. Alsallami, A. A., and R. Kotlowski. 2001. Selection of primers for specific detection of Clostridium botulinum types B and E neurotoxin genes using PCR method. Int. J. Food Microbiol. 69:247-253.
5. Brett, M. M., G. Hallas, and O. Mpamugo. 2004. Wound botulism in the UK and Ireland. J. Med. Microbiol. 53:555-561.
6. Burnens, A. 3 February 2000, posting date. Cases of wound botulism in Switzerland. Eurosurveill. Wkly. 2:000203. http://www. eurosurveillance.org /ew/2000/000203.asp#1.
7. Campbell, K. D., M. D. Collins, and A. K. East. 1993. Gene probes for identification of the botulinal neurotoxin gene and specific identification of neurotoxin types B, E, and F. J. Clin. Microbiol. 31:2255-2262.
8. CDC. 1982. Wound botulism associated with parenteral cocaine abuse, New York City. Morb. Mortal. Wkly. Rep. 31:87-88.
9. Cherington, M. 1998. Clinical spectrum of botulism. Muscle Nerve 21:701-710.
10. Dahlenborg, M., E. Borch, and P. Rådström. 2001. Development of a combined selection and enrichment PCR procedure for Clostridium botulinum types B, E, and F and its use to determine prevalence in fecal samples from slaughtered pigs. Appl. Environ. Microbiol. 67:4781-4788.
11. Dancer, S. J., D. McNair, P. Finn, and A. B. Kolsto. 2002. Bacillus cereus cellulitis from contaminated heroin. J. Med. Microbiol. 51:278-281.
12. Dezfulian, M., L. M. McCroskey, C. L. Hatheway, and V. R. Dowell. 1981. Selective medium for isolation of Clostridium botulinum from human feces. J. Clin. Microbiol. 13:526-531.
13. Dodds, K. L. 1993. Clostridium botulinum in the environment., p. 21-51. In A. H. W. Hauschild and K. L. Dodds (ed.), Food science and technology series, vol. 54. Clostridium botulinum: ecology and control in foods. Marcel Dekker, Inc., New York, NY.
14. Fenicia, L., F. Anniballi, D. De Medici, E. Delibato, and P. Aureli. 2007. SYBR green real-time PCR method to detect Clostridium botulinum type A. Appl. Environ. Microbiol. 73:2891-2896.
15. Franciosa, G., J. L. Ferreira, and C. L. Hatheway. 1994. Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms. J. Clin. Microbiol. 32:1911-1917.
16. Hall, T. A. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41:95-98.
17. Holdeman, L. V., E. P. Cato, and W. E. C. Moore. 1977. VPI anaerobe laboratory manual, 4th ed. Virginia Polytechnic Institute and State University, Blacksburg, VA.
18. Hoorfar, J., N. Cook, B. Malorny, M. Wagner, D. De Medici, A. Abdulmaw-3 jood, and P. Fach. 2003. Making internal amplification control mandatory for diagnostic PCR. J. Clin. Microbiol. 41:5835.
19. Hoorfar, J., B. Malorny, A. Abdulmawjood, N. Cook, M. Wagner, and P. Fach. 2004. Practical considerations in design of internal amplification controls for diagnostic PCR assays. J. Clin. Microbiol. 42:1863-1868.
20. Jensen, T., D. Jacobsen, E. von der Lippe, M. S. Heier, and B. Selseth. 1998. Clinical wound botulism in injecting drug addicts. Tidsskr. Nor. Laegeforen. 118:4363-4365. (In Norwegian.)
21. Jensenius, M., R. Z. Lövstad, G. Dhaenens, and L. M. Rörvik. 2000. A heroin user with a wobbly head. Lancet 356:1160.
22. Kimura, B., S. Kawasaki, H. Nakano, and T. Fujii. 2001. Rapid, quantitative PCR monitoring of growth of Clostridium botulinum type E in modified-atmosphere-packaged fish. Appl. Environ. Microbiol. 67:206-216.
23. Klein, D., P. Janda, R. Steinborn, M. Muller, B. Salmons, and W. H. Gunzburg. 1999. Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification. Electrophoresis 20:291-299.
24. Lindström, M., R. Keto, A. Markkula, M. Nevas, S. Hielm, and H. Korkeala. 2001. Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material. Appl. Environ. Microbiol. 67:5694-5699.
25. Lövenklev, M., E. Holst, E. Borch, and P. Rådströ m. 2004. Relative neurotoxin gene expression in Clostridium botulinum type B, determined using quantitative reverse transcription-PCR. Appl. Environ. Microbiol. 70:2919-2927.
26. Mitchell, P. A., and P. T. Pons. 2001. Wound botulism associated with black tar heroin and lower extremity cellulitis. J. Emerg. Med. 20:371-375.
27. Passaro, D. J., S. B. Werner, J. McGee, W. R. Mac Kenzie, and D. J. Vugia. 1998. Wound botulism associated with black tar heroin among injecting drug users. JAMA 279:859-863.
28. Perelle, S., F. Dilasser, B. Malorny, J. Grout, J. Hoorfar, and P. Fach. 2004. Comparison of PCR-ELISA and LightCycler real-time PCR assays for detecting Salmonella spp. in milk and meat samples. Mol. Cell. Probes 18:409-420.
29. Sandrock, C. E., and S. Murin. 2001. Clinical predictors of respiratory failure and long-term outcome in black tar heroin-associated wound botulism. Chest 120:562-566.
30. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
31. Shapiro, R. L., C. Hatheway, and D. L. Swerdlow. 1998. Botulism in the United States: a clinical and epidemiologic review. Ann. Intern. Med. 129: 221-228.
32. Sieradzan, K. A. 2005. Wound botulism. Pract. Neurol. 5:46-52.
33. Stocher, M., V. Leb, G. Hölzl, and J. Berg. 2002. A simple approach to the generation of heterologous competitive internal controls for real-time PCR assays on the LightCycler. J. Clin. Virol. 25(Suppl. 3):S47-S53.
34. Takeshi, K., Y. Fujinaga, K. Inoue, H. Nakajima, K. Oguma, T. Ueno, H. Sunagawa, and T. Ohyama. 1996. Simple method for detection of Clostridium botulinum type A to F neurotoxin genes by polymerase chain reaction. Microbiol. Immunol. 40:5-11.
35. Werner, S. B., D. Passaro, J. McGee, R. Schechter, and D. J. Vugia. 2000. Wound botulism in California, 1951-1998: recent epidemic in heroin injectors. Clin. Infect. Dis. 31:1018-1024.
36. Yoon, S. Y., G. T. Chung, D. H. Kang, C. Ryu, C. K. Yoo, and W. K. Seong. 2005. Application of real-time PCR for quantitative detection of Clostridium botulinum type A toxin gene in food. Microbiol. Immunol. 49:505-511.